Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ASH17: Benefit of Gilead's CAR-T remains durable over longer term
ASH17: Benefit of Gilead's CAR-T remains durable over longer term
ASH17: Benefit of Gilead's CAR-T remains durable over longer term
Submitted by
admin
on December 10, 2017 - 11:27pm
Source:
BioPharma Dive
News Tags:
ASH17
Gilead Sciences
CAR-T
Yescarta
diffuse large B-cell lymphoma
Headline:
ASH17: Benefit of Gilead's CAR-T remains durable over longer term
Do Not Allow Advertisers to Use My Personal information
